Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-11-18

Clinical Trial Update: A Study to Evaluate the Combination of Valsartan and Amlodipine in Hypertensive Patients Not Controlled on Monotherapy [Phase 3]

View source ↗

Summary

This is a Phase 3 trial evaluating the combination of valsartan and amlodipine for hypertension not adequately controlled on monotherapy. The study has complete…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Amlodipine (amlodipine)
  • VALSARTAN (Valsartan)

Snippet

Sponsor: Novartis | Conditions: Hypertension | Phase 3 | Status: COMPLETED